Alcobra Competitors and Similar CompaniesClear all

Alcobra's competitors and similar companies include Paion and Affimed N.V..
Alcobra
Alcobra
Alcobra is a pharmaceutical company developing new medications to help patients with cognitive disorders, including ADHD and Fragile X Syndrome.
Paion
Paion
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
Affimed N.V.
Affimed N.V.
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
Founding Date
Founding Date
2008
Founding Date
2000
Founding Date
2000
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Tel Aviv-Yafo, IL HQ
Locations
Aachen, DE HQ
Odense, DK
Hoofddorp, NL
Richmond, GB
Locations
Heidelberg, DE HQ
Employees
Employees
19
Employees
3218% decrease
Employees
76
Valuation ($)
Valuation ($)
5.7 m
Valuation ($)
49.7 m
Valuation ($)
52.5 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
€33.2m (FY, 2022)
Revenue (est.)
€8.3m (FY, 2023)
Cost of goods
Cost of goods
N/A
Cost of goods
€382k (FY, 2022)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
€33.4m (FY, 2022)
Gross profit
€13m (FY, 2023)
Net income
Net income
N/A
Net income
(€579k) (FY, 2022)
Net income
(€105.9m) (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

Paion
HQ
Aachen, DE
Employees
32↓ 18% decrease

PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.

View company
Affimed N.V.
HQ
Heidelberg, DE
Employees
76

Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.

View company